ArticleArthritis and rheumatism2011

Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.

Flavia V Castelino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.